What is vascular access? Definitions, clinical context, the full VAD spectrum from peripheral to central, indications for each device type, and who performs vascular access procedures.
The definitive clinical reference on vascular access — device spectrum, evidence-based selection, current clinical standards, complication overview, documentation, and quality metrics for clinicians.
Complete guide to building, measuring, and governing a vascular access team (VAT) program: models, evidence, ROI calculation, quality metrics, scope of practice, and program governance.
Annual state-of-the-practice safety report for vascular access: national CLABSI rates, PICC complication data, peripheral IV failure rates, phlebitis benchmarks, catheter-related DVT epidemiology, and the current evidence base driving vascular access safety standards.
Comprehensive guide to vascular access quality metrics: CLABSI rates and SIR benchmarking, first-attempt success rates, phlebitis rates, catheter utilization ratios, PICC appropriateness tracking, dwell time management, and building a vascular access quality dashboard.
The most comprehensive vascular access knowledge base for clinicians — evidence-based guides on PICC lines, CVCs, CLABSI prevention, complications, ultrasound, credentialing, and infusion therapy.
Clinical reference for vascular access in special populations: pediatric, NICU/neonatal, oncology, hemodialysis, critical care, geriatric, obese, and immunocompromised patients — device selection, technique modifications, and population-specific risks.
Complete comparison of all vascular access device types: PIV, midline, PICC, CVC, tunneled catheter, port, hemodialysis catheter, IO, and arterial line — with a clinical selection guide.
Comprehensive vascular access device (VAD) competency and credentialing checklist covering peripheral IV, midline, PICC, central venous catheter, and implanted port access — including ultrasound guidance competency, bundle compliance verification, and annual maintenance requirements.
Complete guide to vascular access credentialing and certification: VA-BC, CRNI, PICC insertion competency, ultrasound credentialing, institutional privileging, and building a credentialing program.
Free clinical resources for vascular access professionals: safety reports, CLABSI prevention frameworks, competency checklists, and audit tools — designed for hospital educators and VAT program leaders.
Complete ultrasound-guided PICC insertion guide: pre-insertion vein survey, long-axis technique for basilic vein cannulation, guidewire US confirmation, catheter measurement, and intraoperative tip guidance with ECG.
Guide to ultrasound-guided peripheral IV for difficult venous access: DIVA score application, vein selection (diameter, depth), catheter length requirements, short-axis technique, common pitfalls, and when to escalate to midline or PICC.
Comprehensive guide to ultrasound technique for vascular access: probe selection, short-axis vs long-axis approach, in-plane vs out-of-plane needle guidance, dynamic vs static technique, and practical tips for needle visualization.
Framework for ultrasound credentialing in vascular access: didactic requirements, simulation, proctored case minimums, competency assessment, scope of practice definitions, and maintenance of competency requirements per AVAR.
Clinical guide to tunneled central venous catheters: Hickman, Broviac, and Groshong types, indications, care and maintenance, flushing protocols, complication management, and comparison with implanted ports.
The complete clinical reference on PICC lines: indications, ultrasound-guided insertion, CEVAD tip position standards, maintenance protocols, complications, and removal — evidence-based.
Complete step-by-step guide to ultrasound-guided PICC line insertion using the modified Seldinger technique: site selection, vein assessment, catheter measurement, sterile technique, and post-insertion verification.
Clinical indications for PICC line placement — appropriate and inappropriate criteria and MAGIC, PICC for IV antibiotics, chemotherapy, TPN, and vesicants, and absolute contraindications.
Guide to vascular access requirements for parenteral nutrition (PN): central vs peripheral PN access criteria, osmolarity thresholds, PICC vs CVC for TPN, dedicated PN lumen, filtration requirements, administration set change intervals, and DEHP-free requirements.
Comprehensive guide to oncology vascular access: port vs PICC decision-making, chemotherapy central access requirements, vesicant administration, CLABSI prevention in neutropenic patients, power-injectable port selection, and access management across the cancer treatment continuum.
Complete clinical guide to non-tunneled central venous catheters: site selection (IJ vs subclavian vs femoral), ultrasound-guided insertion, complications (pneumothorax, hemothorax, arterial injury), CLABSI prevention, and removal.
Complete NICU vascular access guide: umbilical arterial and venous catheters (UAC/UVC), neonatal PICC lines, neonatal peripheral IV, gestational age considerations, skin protection, heparin-free protocols, and light protection for neonatal PN.
Framework for building an institutional vascular access privileging program: scope of practice delineation, privilege categories, competency documentation, re-privileging, medical staff credentialing vs. nursing competency, and TJC compliance.
Complete guide to IV infiltration and extravasation: infiltration staging scale (0–4), vesicant vs. non-vesicant injury, antidote table (dexrazoxane, hyaluronidase, phentolamine), emergency response, and prevention.
Clinical guide to high-alert IV medications: ISMP list of high-alert medications in vascular access, safety protocols for concentrated KCl, heparin, insulin, opioids, neuromuscular blockers, and chemotherapy — with required safeguards.
Clinical guide to hemodialysis vascular access: AVF creation and maturation criteria, AV graft cannulation, tunneled dialysis catheter placement and complications, vessel preservation in CKD/ESRD, fistula-first policy, buttonhole vs rope-ladder technique, and catheter-to-fistula transition.
Clinical guide to hemodialysis vascular access: AV fistula (preferred), AV graft, and tunneled hemodialysis catheter — indications, care, complications, the access hierarchy, and vessel preservation for CKD patients.
Evidence-based vascular access device selection using standards, the Vessel Health and Preservation (VHP) framework, DIVA score, osmolarity thresholds, and the MAGIC appropriateness criteria.
CVAD tip location standards per CEVAD 2020 consensus: cavoatrial junction target, radiographic landmarks, device-specific tip positions, tip confirmation methods (ECG, CXR, fluoroscopy), and malposition classification.
Clinical guide to critical care vascular access: CVC site selection in the ICU, arterial line placement and management, vasopressor central access requirements, CRRT/CVVHD access, pulmonary artery catheter, CLABSI prevention in the ICU, and simultaneous multi-device management in the critically ill.
Complete overview of CLABSI definition (NHSN criteria), epidemiology (incidence, mortality, cost), CLABSI vs CRBSI distinction, NHSN surveillance methodology, SIR benchmarking, and how CLABSI rates are calculated.
Evidence-based guide to antimicrobial-impregnated catheters (CHG/SS, minocycline-rifampin), antimicrobial dressings, and antimicrobial lock therapy for CLABSI prevention in high-risk settings — indications, evidence, and limitations.
Complete guide to air embolism in vascular access: pathophysiology, prevention during insertion and removal, recognition of venous air embolism, emergency management (Durant's maneuver, aspiration, oxygen therapy), and high-risk scenarios.
Establishes standards for product evaluation, selection, inspection, problem reporting, and supply chain disruption management to ensure vascular access devices and infusion products meet the highest standards of safety, efficacy, and reliability.
Establishes standards for safe handling and disposal of regulated medical waste, sharps safety, needlestick injury prevention, use of safety-engineered devices, injury reporting, and patient and caregiver education for home infusion waste management.
Establishes standards for minimizing latex exposure, identifying at-risk patients and healthcare workers, managing allergic reactions, and ensuring latex-free care environments for latex-sensitive and latex-allergic individuals.
Establishes comprehensive standards for the safe handling, preparation, administration, and disposal of hazardous drugs across all care settings, including PPE requirements, engineering controls, environmental monitoring, spill management, and medical surveillance programs.
Establishes comprehensive standards for preventing, recognizing, and responding to controlled substance diversion in healthcare settings, including chain of custody requirements, waste management, detection methods, and recovery support for affected healthcare workers.
Establishes comprehensive standards for identifying, documenting, investigating, and learning from adverse events, serious adverse events, and near-miss incidents associated with vascular access devices and infusion therapy.
This article examines how elevated cortisol levels—the body's primary stress hormone—affect hospital staff's health and work performance. It explains that healthcare workers face unique stressors such as high-stakes patient care, excessive workloads, and lack of institutional support, which can lead to chronically elevated cortisol and subsequent health issues including anxiety, depression, cognitive impairment, and cardiovascular problems. These effects ultimately reduce work efficiency and can compromise patient safety. The article reviews research on cortisol patterns in emergency care providers, discusses how the COVID-19 pandemic exacerbated these challenges, and offers strategies for managing cortisol levels through lifestyle modifications (exercise, sleep hygiene), stress management techniques (mindfulness, CBT), organizational changes (workload management, flexibility), and when necessary, medical interventions. It concludes by urging healthcare organizations to prioritize staff well-being through transparent, supportive management practices to maintain both employee health and quality patient care.
This comprehensive guide outlines evidence-based principles of vascular access and infusion therapy across the lifespan, including neonatal, pediatric, obstetric, and geriatric populations. It covers regulatory compliance, ethical practice, device selection, infusion accuracy, and population-specific risks such as DEHP exposure, DIVA management, pregnancy-related hypercoagulability, and geriatric polypharmacy. Designed for clinicians, nurses, and vascular access specialists, this resource supports safe, patient-centered decision-making aligned with current standards of care.
Defines the organizational requirements for the assessment, establishment, governance, financial management, and continuous improvement of a dedicated vascular access specialist service, including leadership structure, team nomenclature, budgetary processes, and interprofessional safety integration.
Establishes the organizational model for vascular access service delivery, defining the core service components, operational coverage requirements, consultative approach, and technology integration necessary for a comprehensive, holistic infusion therapy program across inpatient and outpatient settings.
Defines the regulatory hierarchy governing clinician scope of practice, establishes the framework for practice expansion and delegation of vascular access tasks, and delineates the professional roles and responsibilities of all personnel involved in infusion therapy.
Establishes the organizational framework for continuous quality improvement in vascular access services, including the adoption of validated QI methodologies, audit and feedback mechanisms, adverse event surveillance, medication safety integration, and the maintenance of a Just Culture environment.
Mandates comprehensive, health-literacy-appropriate patient and caregiver education for all vascular access and infusion therapy encounters, defines the required educational content, and establishes the teach-back and return demonstration standards for verification of learning.
Mandates the integration of vascular access expertise into cross-disciplinary institutional safety programs and establishes the standards for safe care transitions involving patients with indwelling vascular access devices across acute, community, home, and long-term care settings.
Establishes the legal, ethical, and procedural requirements for obtaining, documenting, and maintaining informed consent for vascular access procedures, including the components of the consent discussion, requirements for emergency situations, and provisions for patients who lack decision-making capacity.
Establishes the foundational principles governing the administration of infusion therapy and the management of vascular access devices across all specialized patient populations, including pediatric, neonatal, obstetric, and geriatric cohorts.
Mandates that all vascular access device selection, antiseptic agent selection, and infusion technology decisions be rooted in demonstrated clinical evidence and patient outcomes, and establishes the systematic clinical monitoring requirements for all vascular access devices.
Establishes the organizational commitment to evidence-based practice in vascular access, mandates the continuous revision of policies based on current research, defines the implementation science framework for translating evidence into bedside practice, and outlines the infrastructure requirements for supporting clinician-researchers.
Establishes the standards, requirements, and minimum data elements for clinical documentation of all vascular access events—from insertion through removal—in the electronic health record, including insertion documentation, ongoing assessment, medication administration, and the integration of EHR clinical decision support tools.
Establishes the standards, framework, and requirements for initial and ongoing competency assessment and validation for all clinicians performing vascular access and infusion therapy procedures, including educational delivery methods, simulation requirements, insertion training protocols, and program evaluation metrics.
Clinical practice guidelines issued by professional organizations — AVA, INS, and others — integrated with The Clinical Database for evidence-based vascular access practice.
Association for Vascular Access (AVA) Adult Clinical Practice Guidelines — JAVA January Supplement 2026, Volume 31. Evidence-based recommendations for vascular access practice.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 5: Comprehensive glossary of vascular access terminology and definitions referenced throughout the guidelines.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 4 covering Sections 5–6: Device Maintenance, Complication Identification & Management, and Special Patient Populations.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 3 covering Sections 3–4: Vascular Access Device Selection, Site Selection, and Insertion Techniques including ultrasound guidance.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 2 continuing Section 1 on implementation considerations, barriers, products, bundles, and checklists for vascular access infrastructure.
Clinical guidelines as static PDFs are failing healthcare. Learn why API-first medical knowledge distribution is essential for modern clinical decision support and how open-source approaches can revolutionize healthcare interoperability.
Establishes standards for the safe insertion of all vascular access devices, including peripheral intravenous catheters, central venous access devices, and arterial catheters, with requirements for aseptic technique, ultrasound guidance, and complication management.
Establishes supplementary infection prevention standards beyond standard precautions for patients with known or suspected communicable disease, including contact, droplet, and airborne precaution requirements, enhanced barrier precautions in long-term care, and crisis standards for pandemic response.
Why IntracavOS moved from cloud APIs to a fully isolated, self-hosted AI system: exploring the security philosophy behind closed-loop healthcare AI and the paranoid approach to patient data protection.
A candid critique of healthcare's resistance to innovation: why vascular access and clinical practice remain stuck in outdated patterns while real problems like CLABSIs persist.
Why we built IntracavOS on NixOS: A reproducible, secure, and scalable operating system designed specifically for healthcare AI deployment. Learn about our architecture and why traditional approaches fail.
Comprehensive guide to preventing hemolysis during blood draws: understanding catheter-to-vein ratio (CVR), cavitation physics, and evidence-based techniques for optimal lab sample quality.
Establishes requirements for skin antisepsis and site preparation prior to vascular access device insertion, including antiseptic selection, application technique, and neonatal-specific precautions.
Evidence-based guidelines for the prevention, assessment, and management of catheter-associated skin injury (CASI) and medical adhesive-related skin injury (MARSI) in patients with peripheral and central vascular access devices, including risk assessment, dressing selection, atraumatic removal techniques, and management of established injury.
Evidence-based standards for subcutaneous infusion therapy including hypodermoclysis, subcutaneous medication administration, continuous subcutaneous insulin infusion, and on-body delivery systems across acute care, ambulatory, and home care settings.
Establishes standards for post-insertion care of all vascular access devices, including systematic assessment protocols, dressing selection and change intervals, skin antisepsis, site protection, infection prevention strategies, documentation requirements, and population-specific considerations.
Evidence-based guidelines for the assessment, prevention, and management of central vascular access device malposition, including primary and secondary malposition types, prevention through insertion technique, diagnostic evaluation, and management approaches including noninvasive and invasive repositioning.
Establishes requirements for evidence-based pain assessment and management during vascular access procedures across all patient populations, from neonates through adults.
Evidence-based standards for the safe insertion, management, medication administration, and complication prevention of neuraxial access devices including epidural and intrathecal catheters, implanted neuraxial ports, and intrathecal drug delivery (ITDD) systems across acute care, outpatient, and home care settings.
Critical analysis of cortisol dysregulation in hospital staff and its impact on clinical performance, patient safety, and healthcare workforce wellbeing with evidence-based interventions.
Evidence-based standards for preventing air embolism during vascular access procedures, including CVAD removal protocols, recognition of signs and symptoms, and emergency response for suspected venous or arterial air embolism.
Establishes requirements for the appropriate selection, use, configuration, labeling, and replacement of primary and secondary administration sets for all infusion types, including standard solutions, parenteral nutrition, lipids, blood products, propofol, and hemodynamic monitoring systems.
Establishes standards for the application of Aseptic Non Touch Technique (ANTT®) across all invasive clinical procedures and vascular access device management, including risk assessment framework, aseptic field management, competency requirements, and environmental management.
Clinical guideline for safe and effective therapeutic phlebotomy practice, including vascular access device selection, treatment parameter establishment, adverse effect prevention and management, psychosocial considerations, patient education, and combination therapy for conditions such as polycythemia vera and hereditary hemochromatosis.
Complete guide to maximizing Lumen effectiveness: best practices for prompting, query formulation, and leveraging AI assistance for vascular access clinical practice and research.
Comprehensive guide to clinical decision-making in vascular access: exploring interprofessional collaboration, evidence-based protocols, and patient-centered care strategies for optimal outcomes.
Evidence-based clinical guidelines for vascular access device removal: comprehensive protocols for PIVCs, midline catheters, and central lines to optimize patient safety and outcomes.
Comprehensive clinical guideline for Peripheral Arterial Disease (PAD) management in vascular access: evidence-based protocols for assessment, prevention, and treatment strategies.
Evidence-based standards for preventing catheter damage, recognizing signs of compromise including pinch-off syndrome, and managing catheter damage through repair, exchange, or removal with post-procedure monitoring requirements.
Establishes comprehensive standards for hand hygiene practice across all care settings, including indications, approved techniques, product selection, fingernail and jewelry standards, and organizational compliance strategies to prevent healthcare-associated infections.
Establishes requirements for the selection, use, configuration, disinfection, and replacement of add-on devices in vascular access infusion systems, including extension sets, manifolds, stopcocks, filters, and closed system transfer devices.
Clinical practice guideline establishing standards for safe and effective implementation of patient-controlled analgesia across healthcare settings, including pharmacologic agents, routes of administration, monitoring requirements, and authorized agent-controlled analgesia protocols.
Establishes standards for protecting vascular access device insertion sites from dislodgement, patient manipulation, and environmental contamination, including joint stabilization practices and the judicious and restrained use of physical immobilization methods.
Evidence-based standards for identifying risk factors for catheter-associated thrombosis, preventing thrombotic complications through device selection and insertion technique, monitoring and diagnosing DVT, and managing confirmed thrombosis including anticoagulation therapy across diverse patient populations.
Establishes standards for flow-control device selection and use in infusion therapy, including electronic infusion pumps, smart pump dose error reduction systems, non-electronic devices, alarm management, and organizational standardization requirements.
Establishes standards for the access, maintenance, dressing, and patient education requirements for implanted vascular access ports, including noncoring needle selection, flushing protocols, power injection verification, and ongoing device surveillance.
Establishes requirements for in-line filtration of parenteral solutions, including mandatory filters for parenteral nutrition and intraspinal infusions, filter selection principles, population-specific indications, change intervals, safety precautions, and prohibited practices.
Evidence-based standards for safe compounding and preparation of parenteral solutions and medications, covering sterile technique, pharmacy-based preparation, vial and ampoule handling, labeling requirements, and competency requirements for all clinicians involved in medication preparation.
Evidence-based standards for safe preparation, handling, and administration of antineoplastic medications including prescribing authorization, occupational safety and PPE requirements, closed system drug transfer devices, spill management, vesicant administration, and adverse reaction protocols.
Standards for preventing, assessing, and managing vascular access device occlusion, including thrombotic and chemical causes, thrombolytic therapy, and catheter clearance agents.
Establishes standards and requirements for flushing and locking all vascular access devices to maintain catheter patency, prevent occlusion, reduce catheter-associated bloodstream infection risk, and ensure safe medication delivery across all device types and patient populations.
Evidence-based standards for preventing, recognizing, and managing bloodstream infections associated with peripheral and central vascular access devices, including care bundles, diagnostic criteria, and device removal decisions.
Evidence-based standards for the clinical evaluation, insertion, management, complication monitoring, and removal of intraosseous vascular access devices across emergent and non-emergent clinical applications in adult and pediatric patients.
Establishes standards for the warming of blood products, intravenous fluids, and contrast media, including device requirements, temperature limits, prohibited methods, monitoring obligations, and quality assurance for all patient populations including neonates.
Establishes requirements for the securement of all vascular access devices to prevent complications associated with dislodgement and movement at the insertion site, including acceptable securement methods, device-specific guidance, and assessment standards.
Establishes baseline infection prevention standards applicable to all patient care activities regardless of diagnosis, including personal protective equipment selection and use, respiratory hygiene, equipment cleaning and disinfection, and care practices across transitional settings.
Establishes standards for hemodialysis vascular access device selection, vessel health and preservation, access hierarchy, infection prevention, hub care, AVF/AVG cannulation, catheter locking solutions, and patient education for patients receiving or anticipated to receive hemodialysis.
Establishes standards for the selection and application of vascular visualization technology—including ultrasound, near-infrared, and visible light devices—to improve vascular access insertion success and reduce complications across all patient populations.
Establishes requirements for selection, disinfection, flushing and clamping sequences, replacement intervals, and infection prevention practices for all needleless connectors used on peripheral and central vascular access devices.
Standards of practice for the prevention, recognition, and management of infiltration and extravasation from peripheral and central vascular access devices, including antidote protocols.
Establishes evidence-based criteria for the selection and planning of vascular access devices across all device types and patient populations, from short peripheral catheters through central venous access devices and arterial catheters.
Evidence-based standards for the classification, prevention, assessment, and management of phlebitis associated with peripheral and central vascular access devices.
Establishes standards for central vascular access device tip location confirmation, including acceptable tip positions, real-time tip location methods, re-evaluation protocols, transfer criteria, and documentation requirements for all patient populations.
policiesClinicianVascular Access
ESC
Type to search policies, guidelines, and blog posts